Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression.

Although the c-Jun NH(2)-terminal kinase (JNK) pathway has been implicated in mediating cell growth and transformation, its downstream effectors remain to be identified. Using JNK2 antisense oligonucleotides (JNK2AS), we uncovered previously a role for JNK2 in regulating cell cycle progression and survival of human PC3 prostate carcinoma cells. Here, to identify genes involved in implementing JNK2-mediated effects, we have analyzed global gene expression changes in JNK2-deprived PC3 cells using Serial Analysis of Gene Expression. More than 40,000 tags each were generated from control and PC3-JNK2AS libraries, corresponding to 15,999 and 20,698 unique transcripts, respectively. Transcripts corresponding to transcription factors, stress-induced genes, and apoptosis-related genes were up-regulated in the PC3-JNK2AS library, revealing a significant stress response after the inhibition of JNK2 expression. Genes involved in DNA repair, mRNA turnover, and drug resistance were found to be down-regulated by inhibition of JNK2 expression, further highlighting the importance of JNK2 signaling in regulating cell homeostasis and tumor cell growth.

[1]  F. Giancotti,et al.  A Requirement for Caveolin-1 and Associated Kinase Fyn in Integrin Signaling and Anchorage-Dependent Cell Growth , 1998, Cell.

[2]  H. G. van der Poel,et al.  Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. , 1993, Cancer research.

[3]  G. Riggins,et al.  Gene discovery using the serial analysis of gene expression technique: implications for cancer research. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Flavell,et al.  Defective T cell differentiation in the absence of Jnk1. , 1998, Science.

[5]  M. Lisanti,et al.  Caveolins in cholesterol trafficking and signal transduction: implications for human disease. , 2000, Frontiers in bioscience : a journal and virtual library.

[6]  M. Gorospe,et al.  c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells* , 2000, The Journal of Biological Chemistry.

[7]  S. Scherer,et al.  Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. , 1996, Human molecular genetics.

[8]  G. Church,et al.  Genomic sequencing. , 1993, Methods in molecular biology.

[9]  N. Holbrook,et al.  Protective Role for c-Jun in the Cellular Response to DNA Damage* , 2001, The Journal of Biological Chemistry.

[10]  B. Monia,et al.  A Role for c-Raf Kinase and Ha-Ras in Cytokine-mediated Induction of Cell Adhesion Molecules* , 1998, The Journal of Biological Chemistry.

[11]  D. Mercola,et al.  The JUN Kinase/Stress-activated Protein Kinase Pathway Is Required for Epidermal Growth Factor Stimulation of Growth of Human A549 Lung Carcinoma Cells* , 1997, The Journal of Biological Chemistry.

[12]  L. Resar,et al.  HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene , 2000, Molecular and Cellular Biology.

[13]  S. Madden,et al.  SAGE transcript profiles for p53-dependent growth regulation , 1997, Oncogene.

[14]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[15]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[16]  O. Potapova,et al.  Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family. , 2000, Methods in enzymology.

[17]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Liscovitch,et al.  Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences , 2000, Glycoconjugate Journal.

[19]  N. Dean,et al.  Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. , 1994, The Journal of biological chemistry.

[20]  V. Fried,et al.  c-Jun NH2-terminal Kinases Target the Ubiquitination of Their Associated Transcription Factors* , 1997, The Journal of Biological Chemistry.

[21]  P. Rakic,et al.  The Jnk1 and Jnk2 Protein Kinases Are Required for Regional Specific Apoptosis during Early Brain Development , 1999, Neuron.

[22]  T. Tan,et al.  The c-Jun N-terminal kinase pathway and apoptotic signaling (review). , 2000, International journal of oncology.

[23]  R. Perez,et al.  Cellular and molecular determinants of cisplatin resistance. , 1998, European journal of cancer.

[24]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[25]  C. Moroni,et al.  c‐jun N‐terminal kinase is involved in AUUUA‐mediated interleukin‐3 mRNA turnover in mast cells , 1998, The EMBO journal.

[26]  M. Ohta,et al.  Expression of a novel immediate early gene during 12-O-tetradecanoylphorbol-13-acetate-induced macrophagic differentiation of HL-60 cells. , 1991, The Journal of biological chemistry.

[27]  Z. Ronai,et al.  Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. , 1996, Oncogene.

[28]  Y. Ip,et al.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.

[29]  M. Lisanti,et al.  Caveolin-1, a putative tumour suppressor gene. , 2001, Biochemical Society transactions.

[30]  Santa Jeremy Ono,et al.  Dynamic Roles in Gene Activation, Development, and Tumorigenesis , 2001 .

[31]  Dirk Bohmann,et al.  Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases , 1997, Science.

[32]  R. Flavell,et al.  Signaling by the JNK Group of MAP Kinases , 2001, Journal of Clinical Immunology.

[33]  M. Gorospe,et al.  Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner , 2000, Molecular and Cellular Biology.

[34]  Dirk Bohmann,et al.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.

[35]  B. Monia,et al.  Evaluation of biological role of c-Jun N-terminal kinase using an antisense approach. , 2000, Methods in enzymology.

[36]  S. Suzuki,et al.  Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells. , 1990, The EMBO journal.

[37]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[38]  K. Umehara,et al.  CROP/Luc7A, a novel serine/arginine‐rich nuclear protein, isolated from cisplatin‐resistant cell line1 , 2000, FEBS letters.

[39]  K. Mühlemann,et al.  Substantially enhanced cloning efficiency of SAGE (Serial Analysis of Gene Expression) by adding a heating step to the original protocol. , 1999, Nucleic acids research.

[40]  B. Monia,et al.  Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. , 2001, Molecular pharmacology.

[41]  R. Flavell,et al.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.

[42]  V. Parnaik,et al.  Functional analysis of the 5' promoter region of the rat lamin A gene. , 1998, DNA and cell biology.

[43]  M. Karin,et al.  Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. , 1998, Science.

[44]  J. Flier.  Pushing the envelope on lipodystrophy , 2000, Nature Genetics.

[45]  T. S. P. S.,et al.  GROWTH , 1924, Nature.

[46]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[47]  P. Rakic,et al.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.

[48]  Leslie M Shaw,et al.  Activation of Phosphoinositide 3-OH Kinase by the α6β4 Integrin Promotes Carcinoma Invasion , 1997, Cell.

[49]  R. Parker,et al.  Functions of Lsm proteins in mRNA degradation and splicing. , 2000, Current opinion in cell biology.

[50]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.